SLE-VTE score
Published by:
Beijing Healthy Cloud Technology Co
Description
SLE-VTE score is a clinical prediction model to help physicians and researchers predict the risk of venous thromboembolism (VTE) in systemic lupus erythematosus (SLE) patients. This model is built and validated based on the Chinese SLE Treatment and Research group cohort (CSTAR). Logistic regression and least absolute shrinkage and selection operator were used to fit the model. The final prediction model (SLE-VTE score) included 11 variables: gender, age, body mass index (BMI), hyperlipidemia, hypoalbuminemia, C-reactive protein (CRP), anti-β2-glycoprotein 1 antibody, lupus anticoagulant, nervous system involvement, renal involvement, and hydroxychloroquine usage. We hope and welcome more cohorts to further validate and improve this model
Hide
Show More...
Screenshots
SLE-VTE score FAQ
-
Is SLE-VTE score free?
Yes, SLE-VTE score is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is SLE-VTE score legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does SLE-VTE score cost?
SLE-VTE score is free.
-
What is SLE-VTE score revenue?
To get estimated revenue of SLE-VTE score app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Egypt yet.
Ratings History
SLE-VTE score Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
SLE-VTE score Installs
Last 30 days
SLE-VTE score Revenue
Last 30 daysSLE-VTE score Revenue and Downloads
Gain valuable insights into SLE-VTE score performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Beijing Healthy Cloud Technology Co
- Languages
- Catalan, English, French, German, Italian, Polish, Portuguese, Chinese, Spanish
- Recent release
- 1.0 (2 years ago )
- Released on
- Jul 12, 2022 (2 years ago )
- Also available in
- Pakistan , Japan , South Korea , Kuwait , Lebanon , Malaysia , Nigeria , Norway , New Zealand , Philippines , Italy , Poland , Saudi Arabia , Singapore , Thailand , Türkiye , Ukraine , United States , Vietnam , South Africa , Denmark , Austria , Australia , Azerbaijan , Belgium , Belarus , Canada , Switzerland , Czechia , United Arab Emirates , Algeria , Egypt , United Kingdom , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel , Germany
- Last Updated
- 1 week ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.